ReviewInternational journal of dermatology2026
Sun Protection Advice for the South African Population for the Prevention and Management of Skin Diseases.
Review in International journal of dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond Tint: Active Ingredient Strategies for Post-Inflammatory Hyperpigmentation due to Visible Light in Skin of Color.Photodermatology, photoimmunology & photomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Sun protection is critical for the prevention and management of skin cancer and other photosensitive dermatoses in South Africa's diverse population. This review expands on previously published sun protection advice for skin cancer prevention by providing tailored advice for individuals with specific dermatological conditions. Recent advances in sunscreen technology, including enhanced protection for long-wave UVA1, visible light, and infrared radiation; inorganic sunscreens with more cosmetic acceptability; and the addition of other active ingredients unrelated to sun protection, are discussed in the context of specific dermatoses. Visible light protection, particularly tinted sunscreens, is particularly relevant for dark to medium skin tones prone to pigmentary disorders, such as melasma and postinflammatory pigmentation. Practical advice is provided for optimizing sun protection in inflammatory conditions, such as acne, rosacea, eczema, and psoriasis, where formulation and tolerability are important for compliance. Photoprotection for photodermatoses and human immunodeficiency virus (HIV)-associated dermatoses is also discussed. Recognizing the economic barriers to sunscreen access, the paper emphasizes the critical role of sun avoidance behaviors, such as sun-protective clothing and seeking shade, in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.